Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Osteoporosis
Interventions: DRUG: zoledronic acid
Sponsor: Herbert Irving Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)